[ad_1]
Associate Prof. Angel Kunchev STAFF: NOVA
The COVID virus not only affects the nasopharynx or the upper respiratory tract. Yes, it enters and multiplies from there, but in practice it is an inflammation of even the smallest vessels, in fact it alters the function of all these manifestations. This was told to NOVA by the Head of State Health Inspectors, Prof. Angel Kunchev
“In adults there are psychological disorders, chronic diseases. We are dealing with a polyvalent virus, quite different from other respiratory viruses, which are limited to sneezing and coughing,” he added.
“In children, it is still small or asymptomatic, but it is not without consequences for them. Peer pediatricians monitor this disease as we prepare to monitor the effect of vaccines. We will have to organize investigations that have been ill for a long time.” Kunchev said.
“We do not have official cases of the new strain. We have probably already imported it, there are many people who work, study, have relatives. The exchange is not small. At Christmas we had 7-8 daily flights. We are currently investigating and awaiting the results. We are looking for people who have a clinic and have resided in the UK, people who have tested positive for protein S and have other antigens. Currently, the most affected country after the UK is Ireland and to some extent the Countries Low, “added the Chief State Inspector.
“We have a little bit of reinfection. To make sure it’s a new disease, you have to analyze it in detail. The person has to show negative results and then show this virus again. There are people who have shown PCR results again. This does not it is decisive, they are below 1%, rather it is an exception ”, he added.
“In most cases, those who have created high immunity with a vaccine, to a small extent, will play the role of infectious agents. It is possible, but the percentage will be many times lower than in non-immunized people,” said the professor. Kunchev.
“Next week I will be vaccinated. I am glad that we will already have the first people with full immunization. From now on it remains to be seen what happens to them, how long this immunity will last,” he added.
“Everything that has come to Bulgaria in the form of vaccines, we have used. Not finishing someone’s vaccination is much worse than not starting it,” said Associate Professor Kunchev.
“In the EU, the AstraZeneca vaccine was expected to be the first to be licensed. I’m sure there will be one by the end of next week. Its distribution suggests easier logistics, it can be stored in a simple refrigerator.” It’s cheap , it is still important. The data on lower efficiency refer to an early stage, I’m sure it won’t be the end result, “he said.
“I am very far from criticizing the Russian vaccine. It should be close to AstraZeneca in terms of qualities. But Russia is not requesting approval in Europe,” said the state inspector.
“I have been dealing with vaccines for 30 years. The problem will be the attitude towards these vaccines and the distrust in the institutions. In 2 months the main problem will be how to explain that we need to be immunized to face this problem,” he added. .
“I do not know what vaccine they will vaccinate me with, what they will vaccinate with on Tuesday or Wednesday when I go to get vaccinated,” he added.
[ad_2]
